ArticleInternational urology and nephrology2018

Risk of renal stone formation in patients treated with luteinising hormone-releasing hormone analogues for prostate cancer: importance of bone metabolism and urine calcium.

Enrique Diaz-Convalia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.